Table 3.
Identified categories of IN by subgroups of people with DM
| Categories | T1DM adults | T1DM children, adolescents | T2DM (including taking oral diabetes medication) | GDM | MODY | Unspecified type of diabetes |
|---|---|---|---|---|---|---|
| (N = 7) | (N = 3) | (N = 14)# | (N = 2) | (N = 1) | (N = 5)$ | |
| Treatment process | [3, 21, 25] [32]* |
[18, 19] | [3, 8, 9, 16, 17, 20, 23–25] [30, 31, 33, 34, 36]* |
[27]* | [3] [26]* |
|
| Course of disease | [3, 21, 25] [6, 32]* |
[18, 19] | [3, 8, 9, 20, 23–25] [28, 31, 33, 36]* |
[22] | [26, 35]* | |
| Abnormalities of glucose metabolism | [19] | [8, 20, 23–25] [33]* |
[27]* | [22] | [3, 4] | |
| Diabetes through the life cycle | [21, 22, 25] [29, 32]* |
[18, 22] | [20] | [22] | [22] | |
| Pathophysiology of diabetes | [19] | [9, 24] | ||||
| Research | [21, 22] [32]* |
[19] | [34]* | [35]* | ||
| Coping | [3, 21] | [18, 19]; | [9, 23] | |||
| Support | [32]* | [34]* | [3] | |||
| Prevention | [8, 9, 20] |
#Twelve studies including IN exclusively of people with T2DM [8, 9, 16, 17, 20, 23, 24, 28, 30, 31, 33, 34, 36], 2 studies including in inter alia people with T2DM [3, 25]
$Three studies where the type of DM of the included population is not defined [22, 26, 35], 2 studies including IN that cannot be assigned certainly to a defined type of DM [3, 4]
*IN: secondary outcome